期刊文献+

结缔组织病并间质性肺病患者血清IL-32、IL-12的临床意义 被引量:6

Clinical Significance of IL-32 and IL-12 serum levels in interstitial lung disease with connective tissue disease
下载PDF
导出
摘要 目的探讨结缔组织病并间质性肺病患者(CTD-ILD)与非结缔组织病引起的间质性肺疾病(IFP+NSIP)患者及正常人外周血血清中白细胞介素32(IL-32)和白细胞介素12(IL-12)水平的差异及意义。方法选择8例结缔组织病并间质性肺病患者(CTD-ILD),其中包括6例类风湿性关节炎(RA)并间质性肺病患者(RA-ILD组),2例硬皮病(SSA)并间质性肺病患者(SSA-LD组);10例非结缔组织病引起的间质性肺疾病(IPF+NSIP),其中包括8例特发性肺间质纤维化患者(IPF组),2例非特异性间质性肺炎患者(NSIP组);选择10例正常人(control组),采用特异的酶联免疫吸附法测定外周血血清中IL-32、IL-12的水平。结果 CTD-ILD组外周血血清中IL-32、IL-12水平明显高于对照组,差异有统计学意义(P<0.05);CTD-ILD组外周血血清中IL-32、IL-12水平明显高于IPF+NSIP组,差异有统计学意义(P<0.05)。 Objective To assess IL-12 and IL-32 serum levels in peripheral blood of patients who sufferd interstitial lung disease with or without connective tissue disease.Methods 8 patients with CTD-ILD, 10 patients with IPF or NSIP, 10 healthy controls were included in this study. Serumconcentrations of IL-32 and IL-12 were measured by ELISA.Results IL-32 and IL-12 serumlevels were significantly higher in the patients of CTD-ILD than those in the control group (P〈0.05). IL-32 and IL-12 serum levels were significantly higher in the patients of CTD-ILD than those in the IPF+NSIP group (P〈0.05).Conclusion The difference in IL-32 and IL-12 levels may help us to to make a right diagnosis about CTD-ILD.
出处 《临床肺科杂志》 2011年第7期1026-1029,共4页 Journal of Clinical Pulmonary Medicine
关键词 IL-32 IL-12 血清 结缔组织病 间质性肺疾病 IL-32 IL-12 serum interstitial lung disease connective tissue disease
  • 相关文献

参考文献17

  • 1叶任高,陆再英主编..内科学[M].北京:人民卫生出版社,2004:1030.
  • 2Wells AU.Lung disease in association with connective tissue diseases J[J].Eur Respir Mon,2000,14:137-164. 被引量:1
  • 3American Thoracic Society/European RespiratorySociety.American Thoracic Society/European Respiratory Society International multidiscipliary consensus classification of the idiopathic interstitial pneumonias[J].Am J Respir Crit Care Med,2002,165:277-304. 被引量:1
  • 4Joosten LA,Netea MG,Kim SH,et al.IL-32,a proinflammatory cytokine in rheumatoid arthritis[J].Proc Natl Acad Sci USA,2006,103:3298-3303. 被引量:1
  • 5Hirofumi S,keishi f,Yumi Y,et al.Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases[J].Arthritis research & theropy,2006,8:R166. 被引量:1
  • 6Shioya M,Nishida A,Yagi Y,et al.Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease[J].Clin Exp Immunol,2007,149:480-486. 被引量:1
  • 7Trinchieri G,Gerosa F et al.Immunoregulation by interleukin-12[J].J Leuk Biol,1996,59:505-11. 被引量:1
  • 8van Veen T,Crusius JB,Schrijver HM,et al.Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis[J].Ann Neurol,2001,50:275. 被引量:1
  • 9American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines.Guidelines for the managements of rheumatoid arthritis[J].Arthritis Rheum,2002,46:328-346. 被引量:1
  • 10Masi AT,Rodnan GP,Medesger TA,et al.Preliminary criteria for the classification of systemic sclerosis (scleroderma).Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee[J].Arthritis Rheum,1980,23:581-590. 被引量:1

同被引文献37

  • 1Palmer G, Talabot-Ayer D, Lamacchia C,et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis [J]. Arthritis Rheum, 2009, 60(3) :738 -749. 被引量:1
  • 2Leonel D, Lucia C, A M, et al. Pulmonary function test: its correlation with pulmonary high-resolution computed tomography in patients with rheumatoid arthritis [ J ]. Rheumatol Irtt, 2012, 32 (7) :2111 -2116. 被引量:1
  • 3Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort[J]. Rheumatology(Oxford) , 2010, 49(8) :1483 - 1489. 被引量:1
  • 4Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family [ J]. Nat Rev Immunol, 2010, 10(2) : 103 -110. 被引量:1
  • 5Marvie P, Lisbonne M, L'helgoualc'h A,et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans [J]. J Cell Mol Med, 2010, lg(6B) :1726-1739. 被引量:1
  • 6Palmer G, Talabot Ayer D, Lamacchia C, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis [J]. Arth Rheum, 2009, 60(3) : 738 -749. 被引量:1
  • 7Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia[J]. Korean J Lab Med,2010,30(4) :406 -413. 被引量:1
  • 8Bauer TT, Ferrer R, Angrill J, et al. Ventilator-associated pneumonia :incidence, risk factors, and microbiology [ J]. Semin Respir Infec t, 2000,15 ( 4 ) : 272 - 279. 被引量:1
  • 9Coppadoro A, Berra L, Bigatello LM. Modifying endotracheal tubes to prevent ventilator-associated pneumonia [ J ]. Curr Opin Infect Dis, 2011,24 ( 2 ) : 157 - 162. 被引量:1
  • 10Joosten LA, Netea MG, Kim SH, et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis [ J]. Proc Natl Acad Sci U S A,2006,103(9) :3 298 -3 303. 被引量:1

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部